1178-2234

Breast Cancer Basic and Clinical Research

Libertas Academica, Ltd.

View prefix report (10.4137)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 148 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact148 DOIs
2

Add abstracts to 10 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact10 DOIs
3

Deposit reference lists for 3 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 147 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Urine Biomarkers of Risk in the Molecular Etiology of Breast… (10.4137/bcbcr.s2112)
Abstract ORCID
71.57 26
2 Quality of Life and Neutropenia in Patients with Early Stage… (10.4137/bcbcr.s2905)
Abstract ORCID
69.01 23
3 Modulation of the BRCA1 Protein and Induction of Apoptosis i… (10.4137/bcbcr.s3067)
Abstract ORCID
58.80 14
4 Breast Cancer: Conventional Diagnosis and Treatment Modaliti… (10.4137/bcbcr.s29420)
ORCID
55.10 159
5 A Review of Systemic Treatment in Metastatic Triple-Negative… (10.4137/bcbcr.s32783)
ORCID
50.00 99
6 Targeting Breast Cancer Metastasis (10.4137/bcbcr.s25460)
ORCID
47.02 75
7 Hereditary Breast Cancer: Clinical, Pathological and Molecul… (10.4137/bcbcr.s18715)
ORCID
43.31 53
8 Five Methods of Breast Volume Measurement: A Comparative Stu… (10.4137/bcbcr.s6128)
ORCID
43.31 53
9 Taxanes for the Treatment of Metastatic Breast Cancer (10.4137/bcbcr.s8205)
ORCID
42.25 48
10 Everolimus in the Treatment of Metastatic Breast Cancer (10.4137/bcbcr.s29268)
ORCID
41.57 45
11 Relevance of Pathological Complete Response after Neoadjuvan… (10.4137/bcbcr.s33163)
ORCID
40.58 41
12 ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Brea… (10.4137/bcbcr.s10701)
ORCID
39.49 37
13 Safety and Efficacy of <i>nab</i>… (10.4137/bcbcr.s5857)
ORCID
39.49 37
14 Oscillation of Clock and Clock Controlled Genes Induced by S… (10.4137/bcbcr.s9673)
ORCID
39.49 37
15 Effects of Celecoxib and Ly117018 Combination on Human Breas… (10.4137/bcbcr.s2291)
Abstract ORCID
38.91 5
16 Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresse… (10.4137/bcbcr.s7156)
ORCID
38.29 33
17 Autophagy and Apoptotic Crosstalk: Mechanism of Therapeutic… (10.4137/bcbcr.s32791)
ORCID
37.63 31
18 Upregulation of Cyclooxygenase-2/Prostaglandin E… (10.4137/bcbcr.s38529)
ORCID
36.93 29
19 Genomic Changes in Normal Breast Tissue in Women at Normal R… (10.4137/bcbcr.s39384)
ORCID
36.18 27
20 Breast Positioning during Mammography: Mistakes to be Avoide… (10.4137/bcbcr.s17617)
ORCID
35.78 26
21 Altered Sirtuin 7 Expression is Associated with Early Stage… (10.4137/bcbcr.s23156)
ORCID
35.78 26
22 Expression of the Androgen Receptor and its Correlation with… (10.4137/bcbcr.s8323)
ORCID
35.78 26
23 Altered Endoplasmic Reticulum Calcium Pump Expression during… (10.4137/bcbcr.s7481)
ORCID
34.95 24
24 Bootcamp during Neoadjuvant Chemotherapy for Breast Cancer:… (10.4137/bcbcr.s9221)
ORCID
34.04 22
25 Combining mTOR Inhibitors with Chemotherapy and Other Target… (10.4137/bcbcr.s10071)
ORCID
33.56 21
26 Subgroup Analyses from a Phase 3, Open-Label, Randomized Stu… (10.4137/bcbcr.s39615)
ORCID
33.56 21
27 Breast Cancer Awareness and Prevention Behavior among Women… (10.4137/bcbcr.s40358)
ORCID
33.56 21
28 Update on Adjuvant Chemotherapy for Early Breast Cancer (10.4137/bcbcr.s9454)
ORCID
33.56 21
29 Protein Kinase C-ε Promotes EMT in Breast Cancer (10.4137/bcbcr.s13640)
ORCID
33.06 20
30 The Possible Impact of Obesity on Androgen, Progesterone and… (10.4137/bcbcr.s7707)
ORCID
33.06 20
31 Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Bre… (10.4137/bcbcr.s13693)
ORCID
31.97 18
32 Breast Cancer Knowledge, Beliefs, and Screening Practices am… (10.4137/bcbcr.s13745)
ORCID
31.97 18
33 Social Support and Hope among Egyptian Women with Breast Can… (10.4137/bcbcr.s6655)
ORCID
31.97 18
34 Coping Strategies in Egyptian Ladies with Breast Cancer (10.4137/bcbcr.s14755)
ORCID
31.38 17
35 Article Commentary: Cost-Effective Screening for Breast Canc… (10.4137/bcbcr.s774)
ORCID
31.38 17
36 ODAM Expression Inhibits Human Breast Cancer Tumorigenesis (10.4137/bcbcr.s6859)
ORCID
30.76 16
37 Increased Circulating Level of the Survival Factor GP88 (Pro… (10.4137/bcbcr.s7224)
ORCID
30.76 16
38 Characterization of a Test for Invasive Breast Cancer Using… (10.4137/bcbcr.s3596)
Abstract ORCID
30.10 3
39 Patient-Reported Outcomes in Metastatic Breast Cancer: A Rev… (10.4137/bcbcr.s39385)
ORCID
30.10 15
40 Association between Vascular Endothelial Growth Factor Gene… (10.4137/bcbcr.s39649)
ORCID
30.10 15
41 Validation of Stereophotogrammetry of the Human Torso (10.4137/bcbcr.s6352)
ORCID
30.10 15
42 Brain Metastases from Breast Cancer and Response to Treatmen… (10.4137/bcbcr.s21176)
ORCID
29.40 14
43 Protective Effect of Piper aduncum Capsule on DMBA-induced B… (10.4137/bcbcr.s24420)
ORCID
29.40 14
44 KDM4C Activity Modulates Cell Proliferation and Chromosome S… (10.4137/bcbcr.s40182)
ORCID
29.40 14
45 Circulating Phospholipids as Biomarkers of Breast Cancer: A… (10.4137/bcbcr.s40693)
ORCID
29.40 14
46 The Efficacy of Intraoperative Frozen Section Analysis durin… (10.4137/bcbcr.s40868)
ORCID
29.40 14
47 Efficacy and Tolerability of Lapatinib in the Management of… (10.4137/bcbcr.s6374)
ORCID
29.40 14
48 Management Options in Triple-Negative Breast Cancer (10.4137/bcbcr.s6562)
ORCID
29.40 14
49 Delivery of MicroRNA-10b with Polylysine Nanoparticles for I… (10.4137/bcbcr.s8513)
ORCID
29.40 14
50 Current Approaches and Emerging Directions in HER2-resistant… (10.4137/bcbcr.s9453)
ORCID
29.40 14